| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 15, 2001
From the Cardiovascular Institute (F.S.V.,
M.C., D.F., J.D.M., B.J.K., J.S.L.), University of Pittsburgh School of
Medicine, Pittsburgh, Pa, and Scios Inc (J.A.A., G.F.S., U.S.),
Sunnyvale, Calif. * To whom correspondence should be addressed. E-mail: villanuevafs{at}msx.upmc.edu.
BackgroundTherapeutic
angiogenesis is a new approach to treating ischemic heart
disease, and the optimal method for assessing its efficacy is unclear.
We used myocardial contrast echocardiography (MCE)
to evaluate the therapeutic response to the angiogenic agent, vascular
endothelial growth factor-121
(VEGF121). Methods and ResultsAfter placement of an ameroid
constrictor (day 0) around the left anterior descending artery (LAD),
dogs were given intracoronary VEGF121
protein (108 µg, n=6) or placebo (n=6) on days 7 and 21, and
subcutaneous VEGF121 (1 mg) or placebo on days 8
to 20 and 22 to 27. On day 48, MCE was performed during rest and
dobutamine stress. Videointensity
(y) and pulsing interval
(t) were fit to an exponential
model
(y=A[1-e-ßt])
used to derive indices of red cell velocity (ß) and capillary area
(A), and parameters
were compared with radiolabeled microsphere flow data.
VEGF121 treatment resulted in higher resting
left anterior descending artery/left circumflex flow ratio compared
with placebo (P<0.03) and
improved collateral flow reserve. ß was 0.94±0.37 in
VEGF121 dogs versus 0.38±0.31 in controls
(P<0.02), with the greatest
difference in the endocardium. The parameter A was comparable in
both groups, suggesting that microvascular changes did not alter
capillary cross-sectional area, and histology indicated a trend toward
higher arteriolar density in VEGF121-treated
animals. ConclusionsVEGF121
protein improves collateral flow and reserve. MCE can evaluate the
transmural location and structural and functional responses of the
microvasculature to angiogenic interventions.
Revised on November 27, 2001
Accepted on December 14, 2001
Myocardial Contrast
Echocardiography Can Be Used to Assess the
Microvascular Response to Vascular Endothelial Growth
Factor-121
This article has been cited by other articles:
![]() |
J. J. Pacella and F. S. Villanueva Effect of Coronary Stenosis on Adjacent Bed Flow Reserve: Assessment of Microvascular Mechanisms Using Myocardial Contrast Echocardiography Circulation, October 31, 2006; 114(18): 1940 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Pacella, M. V. Kameneva, M. Csikari, E. Lu, and F. S. Villanueva A novel hydrodynamic approach to the treatment of coronary artery disease Eur. Heart J., October 1, 2006; 27(19): 2362 - 2369. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Paltiel, L. A. Kalish, R. A. Susaeta, F. Frauscher, P. L. O'Kane, and L. G. Freitas-Filho Pulse-Inversion US Imaging of Testicular Ischemia: Quantitative and Qualitative Analyses in a Rabbit Model Radiology, June 1, 2006; 239(3): 718 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lucidarme, S. Franchi-Abella, J.-M. Correas, S. L. Bridal, E. Kurtisovski, and G. Berger Blood Flow Quantification with Contrast-enhanced US: "Entrance in the Section" Phenomenon--Phantom and Rabbit Study Radiology, August 1, 2003; 228(2): 473 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lu, W. R. Wagner, U. Schellenberger, J. A. Abraham, A. L. Klibanov, S. R. Woulfe, M. M. Csikari, D. Fischer, G. F. Schreiner, G. H. Brandenburger, et al. Targeted In Vivo Labeling of Receptors for Vascular Endothelial Growth Factor: Approach to Identification of Ischemic Tissue Circulation, July 8, 2003; 108(1): 97 - 103. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |